Prospective Comprehensive Genomic Profiling of Primary and Metastatic Prostate Tumors

PURPOSE: Comprehensive genomic profiling (CGP) is increasingly used for routine clinical management of prostate cancer. To inform targeted treatment strategies, 3,476 clinically advanced prostate tumors were analyzed by CGP for genomic alterations (GAs) and signatures of genomic instability. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Jon H., Dewal, Ninad, Sokol, Ethan, Mathew, Paul, Whitehead, Robert, Millis, Sherri Z., Frampton, Garrett M., Bratslavsky, Gennady, Pal, Sumanta K., Lee, Richard J., Necchi, Andrea, Gregg, Jeffrey P., Lara, Primo, Antonarakis, Emmanuel S., Miller, Vincent A., Ross, Jeffrey S., Ali, Siraj M., Agarwal, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Clinical Oncology 2019
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583915/
https://www.ncbi.nlm.nih.gov/pubmed/31218271
http://dx.doi.org/10.1200/PO.18.00283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6583915/
https://www.ncbi.nlm.nih.gov/pubmed/31218271
http://dx.doi.org/10.1200/PO.18.00283

Ejemplares similares